JPH04501365A - 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用 - Google Patents
白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用Info
- Publication number
- JPH04501365A JPH04501365A JP2509217A JP50921790A JPH04501365A JP H04501365 A JPH04501365 A JP H04501365A JP 2509217 A JP2509217 A JP 2509217A JP 50921790 A JP50921790 A JP 50921790A JP H04501365 A JPH04501365 A JP H04501365A
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- cells
- leukocyte adhesion
- receptor
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (23)
- 1.白血球付着受容体β鎖と反応性するモノクローナル抗体を分泌し、このモノ クローナル抗体が細胞間白血球付着を抑止することができる連続ハイブリドーマ 細胞株。
- 2.上記受容体がLFA−1、Mac−1およびLeuM5からなる群の中から 選択される請求項1に記載のハイブリドーマ。
- 3.上記ハイブリドーマがATCC寄託番号HB10160細胞株およびそのイ ンタイプスイッチ変種である請求項1に記載のハイブリドーマ。
- 4.β鎖モノクローナル抗体が細胞間白血球付着を抑止する白血球付着受容体と 反応性するモノクローナル抗体。
- 5.上記受容体がLFA−1、Mac−1およびLeuM5からなる群の中から 選択される請求項4に記載のモノクローナル抗体。
- 6.ATCC寄託番号HB10160細胞株のハイブリドーマから製造されたモ ノクローナル抗体の特異性を有する請求項4に記載のモノクローナル抗体。
- 7.ATCC寄託番号HB10160細胞株のハイブリドーマから製造されたモ ノクローナル抗体。
- 8.白血球付着受容体β鎖のエピトープに結合して細胞間白血球付着を抑止する モノクローナル抗体を治療に有効な量だけ動物に投与することからなる動物の免 疫応答不全疾患を改善する方法。
- 9.上記受容体がLFA−1、Mac−1およびLeuM5からなる群の中から 選択される請求項8に記載の方法。
- 10.上記疾患がAIDS、自己免疫疾患および移植片拒絶反応からなる群の中 から選択される請求項8に記載の方法。
- 11.上記モノクローナル抗体がATCC寄託番号HB10160細胞株から製 造されたモノクローナル抗体の特異性を有する請求項8に記載の方法。
- 12.上記モノクローナル抗体がATCC寄託番号HB10160のハイブリド ーマ細胞株から製造される請求項8に記載の方法。
- 13.上記投与が非経口である請求項8に記載の方法。
- 14.上記非経口投与が皮下、筋肉内、腹腔内、体腔内、経皮または静脈内注射 である請求項13に記載の方法。
- 15.上記投与が投与1回当たり約0.01mg/kgから約2000mg/k gの範囲である請求項8に記載の方法。
- 16.上記モノクローナル抗体が治療用に標識される請求項8に記載の方法。
- 17.上記治療用標識が放射性同位体、医薬、レクチンおよびトクシンからなる 群の中から選択される請求項16に記載の方法。
- 18.モノクローナル抗体H52およびそのインタイプのスイッチ変種の特異性 を有する検出可能な状態に標識されたモノクローナル抗体またはその断片を、診 断上に有効な量だけ、病因を含むと思われる原因源と接触させ、この原因源に上 記抗体が結合したか否かを調べることからなる白血球付着受容体の検出方法。
- 19.上記モノクローナルがATCC寄託番号HB10160のハイブリドーマ 細胞株から製造される請求項18に記載の方法。
- 20.検出をインビボで行う請求項18に記載の方法。
- 21.上記の検出可能な標識が放射性同位体および常磁性体からなる群の中から 選択される請求項20に記載の方法。
- 22.検出をインビトロで行う請求項18に記載の方法。
- 23.上記の検出可能な標識が放射性同位体、蛍光化合物、コロイダル金属、化 学発光性化合物、生物発光性化合物および酵素からなる群の中から選択される請 求項22に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36127189A | 1989-06-02 | 1989-06-02 | |
US361,271 | 1989-06-02 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35508199A Division JP3288996B2 (ja) | 1989-06-02 | 1999-12-14 | 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04501365A true JPH04501365A (ja) | 1992-03-12 |
JP3048632B2 JP3048632B2 (ja) | 2000-06-05 |
Family
ID=23421348
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2509217A Expired - Lifetime JP3048632B2 (ja) | 1989-06-02 | 1990-05-30 | 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用 |
JP35508199A Expired - Lifetime JP3288996B2 (ja) | 1989-06-02 | 1999-12-14 | 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35508199A Expired - Lifetime JP3288996B2 (ja) | 1989-06-02 | 1999-12-14 | 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用 |
Country Status (10)
Country | Link |
---|---|
US (4) | US5888508A (ja) |
EP (1) | EP0432249B1 (ja) |
JP (2) | JP3048632B2 (ja) |
AT (1) | ATE143376T1 (ja) |
AU (2) | AU645016B2 (ja) |
CA (1) | CA2033347C (ja) |
DE (1) | DE69028684T2 (ja) |
DK (1) | DK0432249T3 (ja) |
ES (1) | ES2095876T3 (ja) |
WO (1) | WO1990015076A2 (ja) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5456924A (en) * | 1988-12-23 | 1995-10-10 | Immunotec Research Corporation Ltd. | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
DE69028684T2 (de) * | 1989-06-02 | 1997-05-22 | The Johns Hopkins University School Of Medicine, Baltimore, Md. | Gegen die beta-kette des leukozyten-adhäsions-rezeptors gerichtete monoklonale antikörper, verfahren zu ihrer herstellung und ihre verwendung |
CA2103059C (en) | 1991-06-14 | 2005-03-22 | Paul J. Carter | Method for making humanized antibodies |
US6800738B1 (en) | 1991-06-14 | 2004-10-05 | Genentech, Inc. | Method for making humanized antibodies |
WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
WO1994004188A1 (en) * | 1992-08-21 | 1994-03-03 | Genentech, Inc. | Method for treating an lfa-1-mediated disorder |
US5821332A (en) | 1993-11-03 | 1998-10-13 | The Board Of Trustees Of The Leland Stanford Junior University | Receptor on the surface of activated CD4+ T-cells: ACT-4 |
US5646251A (en) * | 1993-11-05 | 1997-07-08 | The Board Of Trustees Of Leeland Stanford Jr. Univ. | Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily |
US6242566B1 (en) * | 1994-02-10 | 2001-06-05 | Board Of Trustees Of The Leland Stanford Junior University | Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
US5914112A (en) * | 1996-01-23 | 1999-06-22 | Genentech, Inc. | Anti-CD18 antibodies in stroke |
US20020081294A1 (en) | 1996-01-23 | 2002-06-27 | Genentech, Inc. | Co-administration of a thrombolytic and an anti-CD18 antibody in stroke |
US6867203B2 (en) | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
US6582698B1 (en) | 1999-03-19 | 2003-06-24 | Genentech, Inc. | Treatment method |
EP1163003B1 (en) | 1999-03-19 | 2009-08-12 | Genentech, Inc. | Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
WO2001051084A1 (en) * | 2000-01-14 | 2001-07-19 | Genentech, Inc. | Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1 |
JP2003527439A (ja) | 2000-03-17 | 2003-09-16 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 抗cd18抗体と抗ccr2抗体の混合物を用いる狭窄および再狭窄を抑制する方法 |
US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
CA2568570A1 (en) | 2004-06-09 | 2005-12-29 | Genentech, Inc. | Method of treating granuloma annulare or sarcoid |
US8440264B2 (en) * | 2006-12-15 | 2013-05-14 | Ford Global Technologies, Llc | Method for preparing a brazed surface for receiving a coating |
CN102448494B (zh) | 2009-02-13 | 2016-02-03 | 免疫医疗公司 | 具有胞内可裂解的键的免疫共轭物 |
CA2774260C (en) | 2009-09-16 | 2018-10-09 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
CA2782194C (en) | 2009-12-02 | 2018-01-16 | Immunomedics, Inc. | Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer |
JP6024025B2 (ja) | 2011-05-02 | 2016-11-09 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 少容量投与用のアロタイプ選択抗体の限外濾過濃縮 |
CA2874864C (en) | 2012-08-14 | 2023-02-21 | Ibc Pharmaceuticals, Inc. | T-cell redirecting bispecific antibodies for treatment of disease |
PL2900277T3 (pl) | 2012-12-13 | 2022-05-16 | Immunomedics, Inc. | Dawkowanie immunokoniugatów przeciwciał i sn-38 dla poprawy skuteczności i zmniejszenia toksyczności |
WO2017004144A1 (en) | 2015-07-01 | 2017-01-05 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
WO2015126548A1 (en) | 2014-02-21 | 2015-08-27 | Ibc Pharmaceuticals, Inc. | Disease therapy by inducing immune response to trop-2 expressing cells |
WO2015130416A1 (en) | 2014-02-25 | 2015-09-03 | Immunomedics, Inc. | Humanized rfb4 anti-cd22 antibody |
CA2953567C (en) | 2014-06-24 | 2023-09-05 | Immunomedics, Inc. | Anti-histone therapy for vascular necrosis in severe glomerulonephritis |
CN106999517A (zh) | 2014-10-07 | 2017-08-01 | 免疫医疗公司 | 抗体‑药物缀合物的新辅助剂用途 |
EP3029067A1 (en) | 2014-12-01 | 2016-06-08 | Deutsches Krebsforschungszentrum | Use of blocking-reagents for reducing unspecific T cell-activation |
JP6746845B2 (ja) | 2015-04-22 | 2020-08-26 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け |
CN107735104B (zh) | 2015-06-25 | 2022-05-03 | 免疫医疗公司 | 组合抗hla-dr抗体或抗trop-2抗体与微管抑制剂、parp抑制剂、布鲁顿激酶抑制剂或磷酸肌醇3-激酶抑制剂使癌症治疗结果显著改善 |
EP4342497A1 (en) | 2021-05-10 | 2024-03-27 | Kawasaki Institute of Industrial Promotion | Antibody having reduced binding affinity for antigen |
USD1005917S1 (en) * | 2021-11-04 | 2023-11-28 | Thor Tech, Inc. | Wheel |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4506009A (en) * | 1982-03-30 | 1985-03-19 | University Of California | Heterogeneous immunoassay method |
JPH01502879A (ja) * | 1987-02-26 | 1989-10-05 | ダナ ファーバー キャンサー インスティテュート | Lfa―1のクローニング |
US5091513A (en) * | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
US4797277A (en) * | 1987-09-22 | 1989-01-10 | Pharmacia Ab | Method for reperfusion therapy |
US5002869A (en) * | 1987-11-02 | 1991-03-26 | Dana-Farber Cancer Institute | Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes |
EP0314863B1 (en) * | 1987-11-02 | 1994-12-07 | Baylor College Of Medicine | Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation |
GB8726230D0 (en) * | 1987-11-10 | 1987-12-16 | Rosen H | Antibodies |
US5449760A (en) * | 1987-12-31 | 1995-09-12 | Tanox Biosystems, Inc. | Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
US5147637A (en) * | 1988-06-07 | 1992-09-15 | The Rockefeller University | Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma |
ES2077572T3 (es) * | 1988-09-28 | 1995-12-01 | Dana Farber Cancer Inst Inc | Moleculas de adhesion intercelular, y sus ligandos de fijacion. |
CA2000048A1 (en) * | 1988-10-03 | 1990-04-03 | Edward F. Plow | Peptides and antibodies that inhibit integrin-ligand bindin g |
US6307025B1 (en) * | 1989-04-28 | 2001-10-23 | Biogen, Inc. | VCAM fusion proteins and DNA coding therefor |
DE69028684T2 (de) * | 1989-06-02 | 1997-05-22 | The Johns Hopkins University School Of Medicine, Baltimore, Md. | Gegen die beta-kette des leukozyten-adhäsions-rezeptors gerichtete monoklonale antikörper, verfahren zu ihrer herstellung und ihre verwendung |
AU6299390A (en) * | 1989-08-18 | 1991-04-03 | American National Red Cross, The | Fibulin |
US6720141B1 (en) * | 1999-11-01 | 2004-04-13 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for restenosis |
-
1990
- 1990-05-30 DE DE69028684T patent/DE69028684T2/de not_active Expired - Fee Related
- 1990-05-30 AT AT90909864T patent/ATE143376T1/de not_active IP Right Cessation
- 1990-05-30 EP EP90909864A patent/EP0432249B1/en not_active Expired - Lifetime
- 1990-05-30 AU AU58471/90A patent/AU645016B2/en not_active Ceased
- 1990-05-30 CA CA002033347A patent/CA2033347C/en not_active Expired - Lifetime
- 1990-05-30 ES ES90909864T patent/ES2095876T3/es not_active Expired - Lifetime
- 1990-05-30 DK DK90909864.2T patent/DK0432249T3/da active
- 1990-05-30 JP JP2509217A patent/JP3048632B2/ja not_active Expired - Lifetime
- 1990-05-30 WO PCT/US1990/002979 patent/WO1990015076A2/en active IP Right Grant
-
1993
- 1993-10-28 AU AU50353/93A patent/AU666977B2/en not_active Ceased
-
1996
- 1996-02-07 US US08/598,095 patent/US5888508A/en not_active Expired - Lifetime
-
1998
- 1998-11-20 US US09/197,318 patent/US6187308B1/en not_active Expired - Fee Related
-
1999
- 1999-12-14 JP JP35508199A patent/JP3288996B2/ja not_active Expired - Lifetime
-
2001
- 2001-01-16 US US09/761,209 patent/US6921533B2/en not_active Expired - Fee Related
-
2005
- 2005-01-12 US US11/035,214 patent/US7368109B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE143376T1 (de) | 1996-10-15 |
CA2033347C (en) | 2000-02-29 |
WO1990015076A3 (en) | 1991-04-18 |
JP3288996B2 (ja) | 2002-06-04 |
AU5035393A (en) | 1994-02-17 |
US20050158315A1 (en) | 2005-07-21 |
AU5847190A (en) | 1991-01-07 |
WO1990015076A2 (en) | 1990-12-13 |
EP0432249A1 (en) | 1991-06-19 |
US6921533B2 (en) | 2005-07-26 |
CA2033347A1 (en) | 1990-12-03 |
DK0432249T3 (da) | 1997-02-17 |
ES2095876T3 (es) | 1997-03-01 |
DE69028684T2 (de) | 1997-05-22 |
US5888508A (en) | 1999-03-30 |
AU666977B2 (en) | 1996-02-29 |
JP3048632B2 (ja) | 2000-06-05 |
US6187308B1 (en) | 2001-02-13 |
DE69028684D1 (de) | 1996-10-31 |
EP0432249B1 (en) | 1996-09-25 |
AU645016B2 (en) | 1994-01-06 |
EP0432249A4 (en) | 1992-01-02 |
JP2000136200A (ja) | 2000-05-16 |
US7368109B2 (en) | 2008-05-06 |
US20010014325A1 (en) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3288996B2 (ja) | 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用 | |
US4971792A (en) | Monoclonal antibodies against glycolipid antigens | |
EP0280209B1 (en) | Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor | |
JPH0159870B2 (ja) | ||
JPH03502762A (ja) | T細胞抗原レセプターの特定の領域に対して反応性のモノクローナル抗体 | |
JPH0159871B2 (ja) | ||
JPH05504330A (ja) | ヒトのがん腫と反応する新しい抗体 | |
CA2090317A1 (en) | Homoconjugated immunoglobulins | |
JPH0159867B2 (ja) | ||
JPS6410000B2 (ja) | ||
JPH0160231B2 (ja) | ||
US4863730A (en) | Immunotherapy for AIDS patients | |
AU677221B2 (en) | A monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses | |
US5182192A (en) | Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor | |
JPH0159869B2 (ja) | ||
CA2128700A1 (en) | Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor | |
Hall et al. | Tissue Cross‐Reactivity Studies for Monoclonal Antibodies: Predictive Value and Use for Selection of Relevant Animal Species for Toxicity Testing | |
CA2008278A1 (en) | Rat monoclonal antibodies directed against human antigens and processes for preparation thereof | |
JPH02219594A (ja) | 肺癌に対するモノクローナル抗体および細胞表面抗原 | |
Sikora | Monoclonal antibodies and drug targeting in cancer | |
HRP940824A2 (en) | Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods | |
HRP940790A2 (en) | Hybrid cell line for producing monoclonal antibody to a human thymocyte antigen, antibody and method of preparation thereof | |
HRP940823A2 (en) | Hybrid cell line for producing monoclonal antibody to a human early thymocite antigen, antibody and method of preparation of this antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090324 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100324 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110324 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110324 Year of fee payment: 11 |